Top Pharma Acquisitions Looking at Closure in 2024
In 2023, the pharma sector emerged as a pivotal player poised for further evolution and transformative shifts in the year ahead. Stepping into 2024, the pharmaceutical landscape stands at the precipice of transformation, driven by a convergence of key factors reshaping the industry.
The first quarter of 2024 witnessed several acquisitions, while many of the deals from 2023 are still awaiting closure. Let’s now take a closer look at the pharmaceutical deals that we anticipate will be finalized by 2024.
Unlock the Future of Digital Health — Free for 60 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Subscribe Now @ ₹499.00Stay tuned for more such updates on Digital Health News
Follow us
